ESSA Pharma (EPIX) Short Interest Ratio & Short Volume $0.24 +0.00 (+1.31%) Closing price 09/9/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-1.25%) As of 09/9/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESSA Pharma Short Interest DataESSA Pharma (EPIX) has a short interest of 959,100 shares. This marks a 24.49% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 17.37 million shares to cover all short positions.Current Short Interest959,100 sharesPrevious Short Interest770,400 sharesChange Vs. Previous Month+24.49%Dollar Volume Sold Short$1.85 millionShort Interest Ratio0.2 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares47,310,000 sharesPercentage of Shares Shorted2.03%Today's Trading Volume2,567,476 sharesAverage Trading Volume17,373,900 sharesToday's Volume Vs. Average15% Short Selling ESSA Pharma? Sign up to receive the latest short interest report for ESSA Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEPIX Short Interest Over TimeEPIX Days to Cover Over TimeEPIX Percentage of Float Shorted Over Time ESSA Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025959,100 shares $1.85 million +24.5%N/A0.2 $1.93 7/31/2025770,400 shares $1.45 million +12.4%2.1%3.2 $1.88 7/15/2025685,700 shares $1.28 million -8.3%N/A3 $1.87 6/30/2025748,000 shares $1.27 million +4.0%2.0%5.3 $1.70 6/15/2025719,100 shares $1.20 million +4.8%1.9%4.8 $1.67 5/31/2025686,100 shares $1.15 million -1.3%1.8%4.4 $1.68 5/15/2025695,100 shares $1.19 million -2.1%1.9%4.3 $1.71 4/30/2025709,700 shares $1.29 million +12.3%N/A3.6 $1.82 4/15/2025631,800 shares $1.03 million -0.5%1.7%3.3 $1.63 3/31/2025634,900 shares $1.00 million -0.7%1.7%3.7 $1.58 Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 3/15/2025639,100 shares $1.04 million -0.6%1.7%2.6 $1.62 2/28/2025643,100 shares $1.08 million -5.2%1.7%2.3 $1.68 2/15/2025678,200 shares $1.17 million +6.3%1.8%2.2 $1.73 1/31/2025638,200 shares $1.10 million -4.6%N/A1.7 $1.72 1/15/2025668,900 shares $1.18 million -25.8%N/A0.7 $1.76 12/31/2024901,200 shares $1.61 million -5.3%N/A0.9 $1.79 12/15/2024951,500 shares $1.56 million +37.6%N/A1.1 $1.64 11/30/2024691,500 shares $1.24 million -4.8%N/A0.8 $1.79 11/15/2024726,500 shares $1.25 million -36.8%N/A0.9 $1.72 10/31/20241,150,000 shares $5.98 million No ChangeN/A1.5 $5.20 10/15/20241,150,000 shares $6.84 million +2.7%N/A19.5 $5.95 9/30/20241,120,000 shares $6.79 million +4.7%N/A19.8 $6.06 9/15/20241,070,000 shares $7.33 million +3.9%N/A19.1 $6.85 8/31/20241,030,000 shares $5.76 million No ChangeN/A18.9 $5.59 8/15/20241,030,000 shares $4.91 million +3.0%N/A23.6 $4.77 7/31/20241,000,000 shares $5.35 million -1.0%N/A20.4 $5.35 7/15/20241,010,000 shares $5.67 million No ChangeN/A18.7 $5.61 6/30/20241,010,000 shares $5.31 million +14.4%N/A18.4 $5.26 6/15/2024883,100 shares $4.74 million +4.7%N/A14.2 $5.37 5/31/2024843,700 shares $5.69 million -7.6%N/A14.4 $6.75 5/15/2024913,100 shares $5.66 million -1.5%N/A13.9 $6.20 4/30/2024926,500 shares $5.96 million +20.4%N/A8.7 $6.43 4/15/2024769,300 shares $5.62 million -4.2%N/A5.8 $7.30 3/31/2024802,800 shares $6.82 million -13.6%N/A5.2 $8.49 3/15/2024928,600 shares $8.36 million -5.2%4.6%6.1 $9.00 2/29/2024979,400 shares $9.30 million -13.3%4.8%6.3 $9.50 2/15/20241,130,000 shares $11.25 million -19.9%5.6%7.4 $9.96 1/31/20241,410,000 shares $11.69 million +5.2%7.1%9.5 $8.29 1/15/20241,340,000 shares $13.32 million No Change6.7%7.8 $9.94 12/31/20231,340,000 shares $8.84 million -1.5%6.7%6.9 $6.60 12/15/20231,360,000 shares $8.47 million -2.9%6.8%7.1 $6.23 11/30/20231,400,000 shares $7.45 million +1.5%7.0%7.7 $5.32 11/15/20231,380,000 shares $7.25 million +1.5%6.9%7.8 $5.25 10/31/20231,360,000 shares $6.32 million +3,959.7%6.8%8.3 $4.65 10/15/202333,500 shares $91.79 thousand -32.5%0.2%0.3 $2.74 9/30/202349,600 shares $153.26 thousand +73.4%0.3%1.7 $3.09 9/15/202328,600 shares $75.79 thousand -4.7%0.1%0.9 $2.65 8/31/202330,000 shares $90 thousand -42.2%0.2%0.9 $3.00 8/15/202351,900 shares $159.85 thousand +8.1%0.3%1.4 $3.08 7/31/202348,000 shares $144.96 thousand -29.1%0.2%1.3 $3.02 7/15/202367,700 shares $192.95 thousand -27.9%0.4%1.7 $2.85 6/30/202393,900 shares $253.53 thousand -21.6%0.5%1.9 $2.70 6/15/2023119,700 shares $389.03 thousand -18.5%0.6%2.2 $3.25 5/31/2023146,900 shares $440.70 thousand -14.1%0.8%2.2 $3.00 5/15/2023171,000 shares $499.32 thousand -11.2%0.9%2.3 $2.92 4/30/2023192,600 shares $529.65 thousand -33.8%1.0%1.7 $2.75 4/15/2023290,900 shares $805.79 thousand +2.8%1.6%1.9 $2.77 3/31/2023282,900 shares $840.21 thousand -1.4%1.5%1.4 $2.97 3/15/2023287,000 shares $826.56 thousand +21.2%1.5%1.3 $2.88 2/28/2023236,800 shares $796.83 thousand +17.0%1.3%1 $3.37 2/15/2023202,400 shares $718.52 thousand -26.6%1.1%0.7 $3.55 1/31/2023275,800 shares $783.27 thousand -20.6%1.5%0.9 $2.84 1/15/2023347,500 shares $966.05 thousand -1.6%1.9%0.1 $2.78 12/30/2022353,000 shares $889.56 thousand -18.1%1.9%0.1 $2.52 12/15/2022431,100 shares $1.22 million -20.9%2.3%0.1 $2.84 11/30/2022545,000 shares $2.01 million -11.9%2.9%0.2 $3.69 11/15/2022618,300 shares $2.46 million -69.4%3.3%0.2 $3.98 10/31/20222,020,000 shares $7.27 million +472.9%11.6%0.6 $3.60 10/15/2022352,600 shares $691.10 thousand -5.7%2.0%2.1 $1.96 9/30/2022373,800 shares $680.32 thousand +5.4%2.2%1.5 $1.82 9/15/2022354,500 shares $794.08 thousand -5.5%2.0%0.9 $2.24 8/31/2022375,000 shares $967.50 thousand +28.1%2.2%1 $2.58 8/15/2022292,800 shares $878.40 thousand -8.7%1.7%0.7 $3.00 7/31/2022320,800 shares $907.86 thousand -3.2%1.9%0.8 $2.83 7/15/2022331,400 shares $1.05 million -85.2%1.9%0.8 $3.17 6/30/20222,240,000 shares $7.06 million -4.7%12.9%7.4 $3.15 6/15/20222,350,000 shares $10.55 million -7.1%13.5%10.2 $4.49 5/31/20222,530,000 shares $12.78 million +1.2%14.6%9.5 $5.05 5/15/20222,500,000 shares $14.78 million +11.6%14.4%10 $5.91 4/30/20222,240,000 shares $12.70 million +4.7%13.1%9.1 $5.67 4/15/20222,140,000 shares $16.16 million +13.2%12.5%8.7 $7.55 3/31/20221,890,000 shares $11.68 million +81.7%11.0%6.9 $6.18 3/15/20221,040,000 shares $6.56 million +43.6%6.1%4.8 $6.31 2/28/2022724,100 shares $5.92 million +9.8%4.2%4 $8.17 2/15/2022659,800 shares $6.44 million +21.8%3.9%3.2 $9.76 1/31/2022541,800 shares $5.04 million -17.7%3.2%2.1 $9.31 1/15/2022658,100 shares $6.13 million -8.6%3.8%2.5 $9.32 12/31/2021720,200 shares $10.23 million -10.1%4.3%3.1 $14.20 12/15/2021800,900 shares $10.36 million -23.0%4.8%3.2 $12.94 11/30/20211,040,000 shares $13.89 million +11.0%6.2%4 $13.36 11/15/2021937,100 shares $12.17 million -25.0%5.6%3.2 $12.99 10/29/20211,250,000 shares $11.38 million +8.7%7.6%2.5 $9.10 10/15/20211,150,000 shares $9.33 million +2.7%7.0%2.1 $8.11 9/30/20211,120,000 shares $8.96 million -8.2%6.8%1.9 $8.00 9/15/20211,220,000 shares $10.57 million +3.4%7.4%2.1 $8.66 8/31/20211,180,000 shares $11.19 million -28.9%7.2%2.1 $9.48 8/13/20211,660,000 shares $19.79 million +55.1%10.3%3.2 $11.92 7/30/20211,070,000 shares $23.94 million +10.0%6.7%3.5 $22.37 7/15/2021972,500 shares $24.25 million +11.5%6.1%4.1 $24.94 6/30/2021872,200 shares $24.92 million +7.6%5.5%3.9 $28.57 6/15/2021810,600 shares $21.76 million +417.6%5.1%3.6 $26.84 5/28/2021156,600 shares $4.95 million -7.8%1.0%0.6 $31.62 5/14/2021169,900 shares $4.61 million -37.3%1.1%0.7 $27.15 4/30/2021271,000 shares $8.35 million +47.0%1.8%0.8 $30.83 4/15/2021184,300 shares $4.91 million +13.5%1.2%0.5 $26.64 3/31/2021162,400 shares $4.98 million +9.1%1.1%0.4 $30.67 3/15/2021148,900 shares $4.78 million +139.4%1.0%0.4 $32.08 2/26/202162,200 shares $1.58 million -0.8%0.4%0.2 $25.43 2/12/202162,700 shares $1.80 million +37.5%0.4%0.2 $28.65 1/29/202145,600 shares $777.48 thousand +8.3%0.3%0.2 $17.05 1/15/202142,100 shares $666.44 thousand -38.4%0.3%0.2 $15.83 12/31/202068,300 shares $808.67 thousand +349.3%0.5%0.5 $11.84 12/15/202015,200 shares $107.46 thousand +149.2%0.1%0.1 $7.07 11/30/20206,100 shares $39.96 thousand -47.0%0.0%0.1 $6.55 11/15/202011,500 shares $74.41 thousand -9.5%0.1%0.1 $6.47 10/30/202012,700 shares $69.47 thousand +84.1%0.1%0.1 $5.47 10/15/20206,900 shares $46.09 thousand -64.1%0.1%0.1 $6.68 9/30/202019,200 shares $132.48 thousand +62.7%0.1%0.1 $6.90 9/15/202011,800 shares $91.92 thousand -51.4%0.1%0.1 $7.79 EPIX Short Interest - Frequently Asked Questions What is ESSA Pharma's current short interest? Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 959,100 shares of EPIX short. Learn More on ESSA Pharma's current short interest. Which institutional investors are shorting ESSA Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ESSA Pharma: Group One Trading LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ESSA Pharma's short interest increasing or decreasing? ESSA Pharma saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 959,100 shares, an increase of 24.5% from the previous total of 770,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ESSA Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ESSA Pharma: Annovis Bio, Inc. (9.59%), Lantern Pharma Inc. (6.38%), Tempest Therapeutics, Inc. (4.39%), Alterity Therapeutics Limited - Sponsored ADR (0.73%), X4 Pharmaceuticals, Inc. (17.28%), Telomir Pharmaceuticals, Inc. (5.67%), Century Therapeutics, Inc. (3.52%), Acrivon Therapeutics, Inc. (3.18%), Pluri Inc. (0.73%), LAVA Therapeutics N.V. (0.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short ESSA Pharma stock? Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. EPIX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ESSA Pharma? A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further. How often is ESSA Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies ANVS Short Interest Data LTRN Short Interest Data TPST Short Interest Data ATHE Short Interest Data XFOR Short Interest Data TELO Short Interest Data IPSC Short Interest Data ACRV Short Interest Data PLUR Short Interest Data LVTX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EPIX) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
